You searched for "AMN"
Moorfields International Corneal & Cataract Symposium 2024
Mr Alexander Ionides & Mr Mark Wilkins, supported by Théa Pharmaceuticals, NuVison Biotherapies, Altomed Ltd. and Daybreak Medical, are pleased to invite you to register your place for the 2024 Moorfields International Corneal & Cataract Symposium! The programme is under construction and will include 14 talks on current Cornea & Cataract topics from Moorfields, UK and international keynote speakers. Confirmed keynote speakers include Dr Soosan Jacob from Dr Agarwal’s Group of Eye Hospitals, Chennai, India, Prof Adnan Tufail and Prof Paul Foster from Moorfields Eye Hospital NHS Foundation Trust. Thea are pleased to be the gold sponsors of this event along with Altomed, NuVision and Daybreak - silver sponsors.Yorkshire Retina Society Winter Meeting 2024
by Madiah Mahmood, Junior Medical Education Fellow, Bradford Teaching Hospitals and Foundation Trust, UK; Ewan McCallum, Consultant Ophthalmologist, Bradford Teaching Hospitals and Foundation Trust, UK. The Yorkshire Retina Society is one of the largest regional subspecialty societies in the UK,...
Optical Coherence Tomography: A Clinical and Technical Update
This book is a comprehensive review of the clinical and scientific aspects of optical coherence tomography (OCT). The 255 pages are divided into 11 chapters, each written by a different group of authors. Part I provides viewpoints on the clinical...
The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy
The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...
Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients
This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...
The willingness of patients to participate in an eye donation registry for research
This paper explores the willingness of ophthalmic patients to donate their eyes post-mortem for research purposes. A total of 300 German patients with a median age of 70 years (range 19-95) completed the standardised questionnaire; 45.3% were female and the...
